Sanofi (SNY) Other Operating Expenses (2009 - 2026)

Sanofi (SNY) has 13 years of Other Operating Expenses data on file, last reported at -$1.4 billion in Q1 2026.

• Quarterly Other Operating Expenses fell 60.15% year-over-year to -$1.4 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$10.3 billion (down 88.23% YoY) and the FY2025 annual result came in at -$5.1 billion, down 45.81% from the prior year.
• Other Operating Expenses advanced to -$1.4 billion in Q1 2026 per SNY's latest filing, from -$5.1 billion in the prior quarter.
• The five-year high for Other Operating Expenses was -$656.2 million in Q1 2024, with the low at -$5.1 billion in Q4 2025.
• Average Other Operating Expenses over 4 years is -$2.4 billion, with a median of -$2.0 billion recorded in 2026.
• Year-over-year, Other Operating Expenses sank 32.57% in 2024 and sank 247.97% in 2025.
• Sanofi's Other Operating Expenses stood at -$2.7 billion in 2023, then slumped by 32.57% to -$3.5 billion in 2024, then sank by 45.81% to -$5.1 billion in 2025, then jumped by 72.95% to -$1.4 billion in 2026.
• Business Quant data shows SNY's Other Operating Expenses at -$1.4 billion in Q1 2026, -$5.1 billion in Q4 2025, and -$3.8 billion in Q3 2025.